Clinical Trials Sponsored by EnGene, Inc.
Total 37133 results
-
Celgene CorporationCompletedMultiple MyelomaUnited States
-
Celgene CorporationTerminatedMyeloid LeukemiaUnited States
-
Celgene CorporationCompletedSafety and Efficacy of CC-4047 in Subjects With Metastatic Hormone Refractory Prostate Cancer (HRPC)Prostate CancerUnited States
-
Celgene CorporationCompletedMelanoma | Neoplasm MetastasisUnited States, Canada
-
OncoMed Pharmaceuticals, Inc.Celgene CorporationCompletedPancreatic CancerUnited States, Canada, United Kingdom, Spain, Australia, Belgium
-
OncoMed Pharmaceuticals, Inc.Celgene CorporationCompletedNonsquamous Nonsmall Cell Neoplasm of LungSpain, United States, Australia, Italy, Belgium
-
OncoMed Pharmaceuticals, Inc.Celgene CorporationCompletedLocally Advanced or Metastatic Solid TumorsUnited States, United Kingdom
-
Center Eugene MarquisWithdrawn
-
Center Eugene MarquisCompleted
-
Center Eugene MarquisCompletedOropharynx CancerFrance
-
Center Eugene MarquisCompletedLocally Advanced Malignant Neoplasm | Malignant Neoplasm of Head and NeckFrance
-
Center Eugene MarquisCompletedMalignant MelanomaFrance
-
Center Eugene MarquisCompleted
-
Center Eugene MarquisTerminated
-
Center Eugene MarquisCompleted
-
American Gene Technologies International Inc.Completed
-
American Gene Technologies International Inc.Enrolling by invitation
-
American Gene Technologies International Inc.Enrolling by invitation
-
American Gene Technologies International Inc.UnknownHIV InfectionsUnited States
-
CelgeneNot yet recruiting
-
CelgeneNot yet recruiting
-
CelgeneRecruiting
-
CelgeneNot yet recruitingLarge B-cell LymphomaUnited States, Canada, Argentina, Australia, Austria, Brazil, Bulgaria, Chile, China, Colombia, Croatia, Czechia, Denmark, Finland, France, Germany, Greece, Hungary, Japan, Korea, Republic of, Malaysia, Mexico, New Zealand, Norway, Poland, Portug... and more
-
BeiGeneRecruitingNon-small Cell Lung CancerChina, Georgia, Moldova, Republic of
-
BeiGeneRecruitingAdvanced Solid TumorsUnited States, Australia, Spain
-
BeiGeneRecruitingMelanoma | Renal Cell Carcinoma | Urothelial CarcinomaChina
-
BeiGeneRecruitingNon-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerUnited States, China, Australia, Spain, France, Malaysia, Italy, Canada, Thailand, Georgia, Brazil, Korea, Republic of, Singapore, Moldova, Republic of, Romania
-
BeiGeneRecruitingMantle Cell Lymphoma | Relapsed Mantle Cell Lymphoma | Refractory Mantle Cell Lymphoma (MCL)United States, Israel, Belgium, Poland, Spain, Turkey, Brazil, Italy, Canada, United Kingdom, France, Germany, Argentina, Puerto Rico
-
BeiGeneRecruitingA Study of BGB-24714 as Monotherapy and With Combination Therapies in Participants With Solid TumorsSolid Tumor, AdultUnited States, Australia, New Zealand, China, Korea, Republic of
-
BeiGeneRecruitingFollicular Lymphoma | Waldenström Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma | Small Lymphocytic Lymphoma | B-cell MalignancyUnited States, Spain, Italy, Australia, France, Korea, Republic of, United Kingdom, Canada, Brazil, Georgia, Sweden, Germany, Moldova, Republic of
-
CelgeneRecruitingMultiple MyelomaAustria, Italy, China, Australia, Spain, United States, Korea, Republic of, Taiwan, Germany, Ireland, Argentina, Brazil, Mexico, Netherlands, Belgium, Czechia, France, Greece, Japan, Poland, Israel, United Kingdom, Norway, Denmark, Finland and more
-
CelgeneRecruitingMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States, Australia, Spain, Canada, United Kingdom
-
BeiGeneRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Myelodysplastic/Myeloproliferative NeoplasmChina, United States, Australia, Spain, Korea, Republic of, New Zealand, Germany
-
BeiGeneRecruitingAdvanced Solid TumorChina, United States, Australia, New Zealand, Korea, Republic of
-
BeiGeneRecruitingMature B-Cell MalignanciesUnited States, Italy, Australia, New Zealand, Spain, United Kingdom, Germany
-
CelgeneRecruitingLymphoma, Non-HodgkinUnited States, Korea, Republic of, China, Canada, France, Spain, Denmark, Brazil, Italy, Argentina, Chile, Israel, United Kingdom, Belgium, Austria
-
CelgeneRecruitingNeoplasmsUnited States, Belgium, Spain, Switzerland, Canada, France, Germany, Japan, Finland, United Kingdom, Austria, Italy, Netherlands, Norway, Sweden
-
CelgeneRecruitingMultiple MyelomaKorea, Republic of
-
CelgeneRecruitingMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Primary MyelofibrosisUnited States, Puerto Rico
-
BeiGeneActive, not recruitingMature B-cell MalignanciesChina
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Germany, Italy, Spain, Sweden, Japan
-
CelgeneActive, not recruitingGlioblastoma | AstrocytomaUnited States, Spain
-
BeiGeneActive, not recruitingNon Small Cell Lung CancerChina
-
CelgeneActive, not recruitingCrohn DiseaseUnited States, Italy, Germany, Russian Federation, Argentina, Australia, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Chile, Croatia, Czechia, Denmark, Finland, France, Georgia, India, Ireland, Israel, Korea, Republic... and more
-
CelgeneTerminatedNon Small Cell Lung CancerUnited States
-
BeiGeneCompletedNon-small Cell Lung CancerChina, Russian Federation, New Zealand, Lithuania, Turkey, Brazil, Bulgaria, Poland, Mexico, Slovakia
-
BeiGeneCompletedHepatocellular Carcinoma | Unresectable Hepatocellular Carcinoma | Metastatic Hepatocellular CarcinomaChina
-
BeiGeneActive, not recruitingNon Small Cell Lung Cancer | Advanced Solid Tumor | Head and Neck Squamous Cell Carcinoma (HNSCC) | Nasopharyngeal Carcinoma (NPC)Canada, Australia, New Zealand, Korea, Republic of, United States, Malaysia, Thailand
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Canada, Italy, Czechia, Denmark, France, Germany, Greece, Spain
-
BeiGeneActive, not recruitingRelapsed/Refractory Follicular Non-Hodgkin LymphomaKorea, Republic of, New Zealand, United States, China, Taiwan, Spain, Italy, Australia, Canada, United Kingdom, Belarus, Bulgaria, Czechia, France, Germany, Poland, Russian Federation